Ambu A/S (OTCMKTS:AMBBY) Sees Large Volume Increase - Here's What Happened

Key Points

• The shares of Ambu A/S experienced a significant volume increase of 1,026% on Wednesday, with approximately 9,051 shares changing hands.
• UBS Group has upgraded Ambu A/S to a "strong-buy" rating, contributing to a current consensus rating of "Strong Buy" among analysts.
• Ambu A/S reported earnings of $0.07 EPS and revenue of $229.16 million for the most recent quarter, indicating a net margin of 5.93%.

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY - Get Free Report) shares saw unusually-high trading volume on Wednesday . Approximately 9,051 shares changed hands during trading, an increase of 1,026% from the previous session's volume of 804 shares.The stock last traded at $15.24 and had previously closed at $15.42.

Wall Street Analyst Weigh In

Separately, UBS Group raised Ambu A/S to a "strong-buy" rating in a research note on Tuesday, May 13th. One research analyst has rated the stock with a Strong Buy rating, According to MarketBeat, the stock currently has a consensus rating of "Strong Buy".

Ambu A/S Trading Down 1.2%

The stock's fifty day moving average price is $15.07 and its two-hundred day moving average price is $16.03. The stock has a market capitalization of $3.58 billion, a P/E ratio of 80.21 and a beta of 0.88. The company has a current ratio of 2.88, a quick ratio of 1.67 and a debt-to-equity ratio of 0.08.

Ambu A/S (OTCMKTS:AMBBY - Get Free Report) last posted its earnings results on Friday, August 22nd. The company reported $0.07 earnings per share (EPS) for the quarter. The company had revenue of $229.16 million for the quarter. Ambu A/S had a return on equity of 6.24% and a net margin of 5.93%.

About Ambu A/S

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.